Offer - Urjas Oil for just ₹ 1 X
Glimepiride + Metformin + Voglibose is an allopathic medicine The correct dosage of Glimepiride + Metformin + Voglibose depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Glimepiride + Metformin + Voglibose is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glimepiride + Metformin + Voglibose safe for pregnant women?
Glimepiride + Metformin + Voglibose can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Glimepiride + Metformin + Voglibose right away. Take your doctor's advice before taking it again.
Is the use of Glimepiride + Metformin + Voglibose safe during breastfeeding?
Glimepiride + Metformin + Voglibose is completely safe for breastfeeding women.
What is the effect of Glimepiride + Metformin + Voglibose on the Kidneys?
Glimepiride + Metformin + Voglibose may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glimepiride + Metformin + Voglibose on the Liver?
Glimepiride + Metformin + Voglibose can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Glimepiride + Metformin + Voglibose on the Heart?
You may experience side effects on your heart after taking Glimepiride + Metformin + Voglibose. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Glimepiride + Metformin + Voglibose should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Unknown
If you are suffering from any of the following diseases, you should not take Glimepiride + Metformin + Voglibose unless your doctor advises you to do so -
Is this Glimepiride + Metformin + Voglibose habit forming or addictive?
Forming a habit of Glimepiride + Metformin + Voglibose has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Glimepiride + Metformin + Voglibose since it will not make you feel sleepy.
Is it safe?
Yes, but take Glimepiride + Metformin + Voglibose only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Glimepiride + Metformin + Voglibose for mental disorders.
Interaction between Food and Glimepiride + Metformin + Voglibose
Taking Glimepiride + Metformin + Voglibose with food is safe.
Interaction between Alcohol and Glimepiride + Metformin + Voglibose
Consumption of alcohol and Glimepiride + Metformin + Voglibose together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277